Viyash Scientific Limited (VIYASH) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Viyash Scientific Limited stock ₹79.76, price ₹236, that is 66.3% below the price, quality 38 out of 100. Rating: strongly overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Viyash Scientific Limited
VIYASH · NSEFar too expensive (fair value 66% below the price) and weak company.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.
How to read this chart
10‑month range ₹179.89 – ₹294.15 · fair‑value band ₹42.31 – ₹104.69 · the ₹236.38 price screens above the ₹79.76 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 11, 2026.
Every Wednesday you see whether Viyash Scientific is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally.
Show moreShow less
The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services.
The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.
Stock analysis
Viyash Scientific Limited (VIYASH) currently trades at ₹236.38, while our model-based Fair Value estimate is ₹79.76, 66% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹113.18 per share, and 0 of the 24 models we run sit above the ₹236.38 price.
Bear case: the Asset-Based group reads lowest at ₹23.51, and 24 of the 24 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹42.31 (bear) to ₹104.69 (bull), the price of ₹236.38 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Viyash Scientific Limited reported revenue of ₹34.2B in FY2026 versus ₹14.1B in FY2022, a compound +24.8%/yr. Reported net income was ₹1.8B in FY2026, compounding +44.2%/yr from FY2022.
Key figures
Market cap ₹105B (≈ $1.1B) Small · P/E ratio 58.8 · P/S ratio 4.00 · EPS (TTM) ₹4.02 · Net margin 5.9% · Return on equity 7.9% · Return on assets (EBIT) 8.8% (5-year average) · Operating margin 12.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 40 out of 100 (medium confidence).
What moves the price
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −66%, VIYASH screens richer than that median.
Fair Value models
All 24 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
VIYASH screens overvalued: fair value 66% below the price. Compare with Merck KGaA →
Compare Viyash Scientific Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs VIYASH |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.07 | ¥53.04 | +10% | vs VIYASH |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,880 | ₹1,983 | +5% | vs VIYASH |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs VIYASH |
| Merck KGaA MRK | €149.60 | €108.83 | −27% | vs VIYASH |
| Galderma Group GALD | CHF 191.40 | CHF 112.30 | −41% | vs VIYASH |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs VIYASH |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs VIYASH |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs VIYASH |
| Divi's Laboratories Limited DIVISLAB | ₹11,442 | ₹1,567 | −86% | vs VIYASH |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Viyash Scientific Limited (VIYASH) overvalued or undervalued?
What is the fair value of VIYASH?
What is the quality score of VIYASH?
What is the price target for Viyash Scientific Limited (VIYASH)?
What is the Viyash Scientific Limited stock forecast for 2026?
What is the revenue of Viyash Scientific Limited (VIYASH)?
What growth is priced into Viyash Scientific Limited (VIYASH)?
What discount rate (WACC) does the fair value of VIYASH use?
What is a reverse DCF?
How much growth has Viyash Scientific Limited (VIYASH) delivered so far?
How fast is the sector of Viyash Scientific Limited (VIYASH) growing?
What is the free cash flow yield of Viyash Scientific Limited (VIYASH)?
What is the intrinsic value of Viyash Scientific Limited (VIYASH)?
Is Viyash Scientific Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of VIYASH?
How much is Viyash Scientific Limited worth?
What do the bullish and bearish scenarios say about VIYASH?
What is the P/E ratio of VIYASH?
How solid is the balance sheet of Viyash Scientific Limited (VIYASH)?
Which stocks are comparable to Viyash Scientific Limited?
Is Viyash Scientific Limited stock attractive at the current price?
How is the fair value of VIYASH calculated?
Is it still worth investing in stocks now?
What is the share price of Viyash Scientific Limited (VIYASH)?
What should I pay attention to with Viyash Scientific Limited right now?
Key figures of Viyash Scientific Limited
How large is the market capitalisation of Viyash Scientific Limited (VIYASH)?
What is the P/S ratio of Viyash Scientific Limited (VIYASH)?
What are the earnings per share of Viyash Scientific Limited (VIYASH)?
What is the net margin of Viyash Scientific Limited (VIYASH)?
What is the return on equity of Viyash Scientific Limited (VIYASH)?
What is the EBIT return on assets of Viyash Scientific Limited (VIYASH)?
What is the operating margin of Viyash Scientific Limited (VIYASH)?
How fast is revenue growing at Viyash Scientific Limited (VIYASH)?
How fast are earnings growing at Viyash Scientific Limited (VIYASH)?
How much net debt does Viyash Scientific Limited (VIYASH) carry?
Watch Viyash Scientific Limited in the live analysis
One click puts Viyash Scientific Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.